This study is currently not recruiting participants.

NILO-PD Biorepository: A biospecimen repository for clinical trials of nilotinib in Parkinson's Disease

Study of Biological Samples for Drug Processing and Disease Indicators

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The purpose of this study is to receive, process, maintain, and distribute biological specimens collected through the NILO-PD clinical trials for the purpose of pharmacokinetic (PK) and biomarker analysis.

Detailed description of study

The purpose of this study is to receive, process, maintain, and distribute biological specimens collected through the NILO-PD clinical trials for the purpose of pharmacokinetic (PK) and biomarker analysis.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Parkinson's disease
  • Age: 100 years or below
  • Gender: All

The purpose of this study is to receive, process, maintain, and distribute biological specimens collected through clinical trials. Pharmacokinetic analysis involves studying how the body absorbs, distributes, metabolizes, and excretes a drug. Biomarker analysis involves examining biological indicators that can help understand disease processes.

Participants in the study will have biological specimens collected for analysis. These specimens will be used to study how the body processes the investigational medication and to identify markers that could indicate how a disease progresses or responds to treatment.

  • Who can participate: Eligibility criteria are not specified in the provided information.
  • Study details: Participants will provide biological samples, which will be analyzed for pharmacokinetics and biomarkers.
Updated on 19 Feb 2024. Study ID: 1707494758

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team